Chu Liege

Liège B-4000

3 studies enrolling now · 13 studies all time

What they study most

ADPKD, Acute Myeloid Leukemia, Autosomal Dominant Polycystic Kidney, Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml, Glabellar Lines, HER2-Positive Primary Breast Cancer, Metastatic Breast Cancer, Myelodysplastic Syndrome, Ovarian Cancer, Prostate Cancer

Studies at this site

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia — Recruiting now
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02 — Recruiting now
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer — Completed
MT10109L in the Treatment of Glabellar Lines — Completed
Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients — Completed
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) — Completed
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed